¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tissue maximum ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • adipose tissue
    Áö¹æÁ¶Á÷
  • compact tissue
    Ä¡¹ÐÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • elastic tissue
    ź·ÂÁ¶Á÷
  • epithelial tissue
    »óÇÇÁ¶Á÷
  • erectile tissue
    ¹ß±âÁ¶Á÷
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷, À忬°ü¸²ÇÁÁ¶Á÷
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷, Á¶Ç÷Á¶Á÷
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • lymphatic tissue
    ¸²ÇÁÁ¶Á÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • soft tissue
    ¿¬Á¶Á÷, ¹°··Á¶Á÷
  • subcutaneous tissue
    ÇǺιØÁ¶Á÷, ÇÇÇÏÁ¶Á÷
  • tissue typing
    Á¶Á÷Çü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • maximum surgical blood order schedule
    ÃÖ´ë¼ö¼úÇ÷¾×¿äû°èȹǥ, ÃÖ´ë¼ö¼úÇ÷¾×½Åû·®
  • maximum tubular transport
    ÃÖ°í¿ä¼¼°üÀ̵¿Ä¡
  • maximum urethral closure pressure
    ÃÖ°í¿äµµÆó¼â¾Ð
  • maximum voiding rate
    ÃÖ°í¹è´¢À²
  • tubular maximum
    ¿ä¼¼°üÃÖ´ë°ª
  • acute normal tissue effect
    Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
  • adipose tissue
    Áö¹æÁ¶Á÷
  • tissue antibody
    Á¶Á÷Ç×ü
  • tissue biopsy
    Á¶Á÷»ý°Ë
  • compact tissue
    Ä¡¹ÐÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primitive connective tissue
    ¿ø½Ã°áÇÕÁ¶Á÷(¡­Ì¿ùêðÚòÄ) °£¿±(Êàç¨) .
  • regular connective tissue
    ±ÔÄ¢¼º °áÇÕÁ¶Á÷, Á¤Çü°áÇÕÁ¶Á÷(ïáû¡Ì¿ùêðÚòÄ).
  • renewal tissue
    Àç»ýÁ¶Á÷
  • DeRitis ratio
    µå¸®Æ¼½ººñÀ²
  • Donnan ratio
    µ·³­À²
  • G/N ratio
    G/Nºñ Æ÷µµ´ç°ú Áú¼ÒÀÇ ºñÀ² .
  • INR => International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio=INR
    ±¹Á¦Á¤»óÈ­ºñ
  • L/S ratio
    L/S ºñÀ²
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • S-D ratio
    ¼öÃà±â-À̿ϱ⠺ñ (â¥õêÑ¢-ì¬èÐÑ¢ Ýï)
  • SNR (signal to noise ratio)
    ½ÅÈ£´ë ÀâÀ½ºñÀ²
  • V/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ùºñ
  • VA/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ù ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum heart rate
    ÃÖ´ë½É¹Ú¼ö.
  • maximum intensity projection
    ÃÖ´ë°­µµ Åõ»ç
  • maximum mid-expiratory flow rate
    ÃÖ´ëÁß°£È£±â À¯Ãâ¼Óµµ
  • maximum midexpiratory flow
    ÃÖ´ëÈ£±âÁß°£À¯·®(¡­û¼Ñ¨ñéÊàêüåÖ).
  • maximum oxygen consumption
    ÃÖ´ë»ê¼Ò¼Ò¸ð·®.
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä·®(õÌÓÞß«áÈݶóðåÖ).
  • maximum permissible concentration =MP
    ÃÖ´ëÇã¿ë³óµµ(¡­úÉé»ÒØöô).
  • maximum permissible concentration =MPC
    ÃÖ´ëÇã¿ë³óµµ(¡­úÉé»ÒØöô).
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(ÊÙËâ).
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(¡­åÖ).
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ.
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè(õÌÓÞúÉé»ùÚÍ£).
  • maximum phonation time
    ÃÖÀå ¹ß¼ºÁö¼Ó½Ã°£
  • maximum power output =MPO
    ÃÖ´ëÃâ·Â
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¼Æ÷
  • Myeloid tissue
    °ñ¼öÁ¶Á÷
    [¿¾ ¿ë¾î] °ñ¼ö¾çÁ¶Á÷
  • Myeloid tissue
    °ñ¼öÁ¶Á÷ [»À¼ÓÁúÁ¶Á÷]
    [¿¾ ¿ë¾î] °ñ¼ö¾çÁ¶Á÷
  • Lymphoid tissue
    ¸²ÇÁÁ¶Á÷
    [¿¾ ¿ë¾î] ÀӯľçÁ¶Á÷
  • Lymphoid tissue
    ¸²ÇÁÁ¶Á÷
    [¿¾ ¿ë¾î] ÀÓÆÄÁ¶Á÷
  • Osteogenic tissue
    »À¹ß»ýÁ¶Á÷
    [¿¾ ¿ë¾î] Á¶°ñÁ¶Á÷
  • Bone tissue
    »ÀÁ¶Á÷
    [¿¾ ¿ë¾î] °ñÁ¶Á÷
  • Epithelioid tissue
    »óÇǸð¾çÁ¶Á÷
    [¿¾ ¿ë¾î] »óÇǾçÁ¶Á÷
  • Pigment connective tissue
    »ö¼Ò°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] »ö¼ÒÁ¶Á÷
  • Reticulofibrous bone tissue
    ¼¼¸Á¼¶À¯»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸Á¼¶À¯¼º°ñÁ¶Á÷
  • Connective tissue of endometrium
    ÀڱüӸ·°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Àڱ󻸷°áÇÕÁ¶Á÷
  • Subserous tissue
    À帷¹ØÁ¶Á÷
    [¿¾ ¿ë¾î] À帷ÇÏÁ¶Á÷
  • Submucous tissue
    Á¡¸·¹ØÁ¶Á÷
    [¿¾ ¿ë¾î] Á¡¸·ÇÏÁ¶Á÷
  • Mucous connective tissue
    Á¡¾×°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Á¡¾×°áÇÕÁ¶Á÷
  • Osteoid tissue
    Dz»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] °ñ¾çÁ¶Á÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • channels ratio method
    ä³Î ºñÀ²¹ý(Ýï×ËÛö)
  • coding ratio
    ºÎÈ£ºñ(ݬûÜÝï)
  • dichroic ratio
    ÀÌ»öºñ(ì£ßäÝï)
  • disequilibrium ratio
    ºÒÆòÇü ºñÀ²(ÝÕøÁû¬Ýï×Ë)
  • dissymmetry ratio
    ºÒ¿ÏÀü´ëĪ ºñÀ²(ÝÕèÇîïÓßöàÝï×Ë)
  • distribution ratio
    "ºÐÆ÷À²(ÝÂøÖëÒ), (ÔÒ) partition coefficient"
  • Donnan ratio
    µ·³­ À²(ëÒ)
  • extraction ratio
    ÃßÃâºñ(õÎõóÝï)
  • flux ratio method
    Çöô½º ºñÀ²¹ý(Ýï×ËÛö)
  • frictional ratio
    ¸¶Âûºñ(ؤóÍÝï)
  • G + C/A + T ratio
    G + C/A + T ºñ(Ýï)
  • gyromagnetic ratio
    ÀÚ±âȸÀü ºñ(í¸Ñ¨üÞï®Ýï)
  • ratio
    ºñÀ²(Ýï×Ë)
  • induction ratio
    À¯µµºñ(ë¯ÓôÝï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • osteoblastic tissue
    °ñÇü¼ºÁ¶Á÷
  • proper connective tissue
    °íÀ¯°áÇÕÁ¶Á÷
  • pseudogating in flowing tissue
    À¯µ¿Á¶Á÷¿¡¼­ À§°ÔÀÌÆÃ
  • reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
  • reticular tissue
    ¼¼¸ÁÁ¶Á÷
  • retropharyngeal soft tissue space
    ÀεÎÈĺο¬ºÎÁ¶Á÷
  • scar tissue
    ¹ÝÈçÁ¶Á÷
  • soft tissue
    ¿¬Á¶Á÷
  • soft tissue calcification
    ¿¬Á¶Á÷¼®È¸È­
  • soft tissue technique
    ¿¬Á¶Á÷±â¹ý
  • stationary tissue
    Á¤Á¶Á÷
  • surrounding tissue
    ÁÖÀ§Á¶Á÷
  • tissue
    Á¶Á÷
  • tissue anoxia
    Á¶Á÷¹«»ê¼ÒÁõ
  • tissue characterization
    Á¶Á÷Ư¼º°¨º°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MPI mannose phosphate isomerase; master patient index; maximum permitted intake; maximum point of impuls...
MTC mass transfer coefficient; maximum tolerated concentration; maximum toxic concentration; medical tes...
Tmax maximum threshold; time of maximum concentration
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
TCID tissue culture infective dose; tissue culture inoculated dose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MLS Maximum Length Sequences
ML Maximum Likelihood
MLE Maximum Likelihood Estimate
MLE Maximum Likelihood Estimation
MLE Maximum Likelihood Estimator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • child woman ratio
    ¸ð¾Æ ºñÀ²
  • crown-root ratio
    Ä¡°ü´ë Ä¡±Ùºñ
  • curative ratio
    Ä¡À¯À²
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • effective ratio
    À¯È¿À²
    ¾î´À ÇѰè±îÁö´Â ¾àÁ¦ ¿ë·®°ú À¯È¿À²Àº ºñ·ÊÇÑ´Ù. ÇѰè À̻󿡼­´Â ºÎÀÛ¿ëÀÌ ³ªÅ¸³­´Ù.
  • expansion ratio
    ÆØÃ¢ºñ
  • innervation ratio
    ½Å°æ Áö¹è ºñ
  • magnetization transfer ratio
    ÀÚÈ­ Àü´Þ ºñÀ²
  • mercuryalloy ratio
    ¼öÀº Çձݺñ
  • monocyte lymphocyte ratio
    ´Ü±¸ ¸²ÇÁ±¸ºñ
  • optimal ratio
    ÃÖÀûºñ
  • optimum ratio
    ÃÖÀûºñ
  • phase ratio
    »óºñ
  • ratio
    ºñ
    ¾î¶² ¹°Áú ¶Ç´Â ½ÇüÀÇ ¾çÀ» ´Ù¸¥ °Í°ú ºñ±³ÇÑ Ç¥ÇöÀ¸·Î¼­, º¸Åë ÇÑÂÊÀÇ ¾çÀ» ´Ù¸¥ÂÊÀÇ ¾çÀ¸·Î ³ª´« °ªÀ¸·Î Ç¥½ÃÇÑ´Ù.
  • sex ratio
    ¼ººñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
ventilation-perfusion ratio The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung.
(12 Dec 1998)
ventilation/perfusion ratio The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung; because both ventilation and perfusion are expressed per unit volume of tissue and per unit time, which cancel, the units become liters of gas per liter of blood.
(05 Mar 2000)
mass-action ratio The ratio of the product of all of the product concentrations divided by the product of all of the reactant concentrations of a particular reaction; when the reaction has been completed (i.e., t = ∞), then this ratio is equal to the equilibrium constant.
(05 Mar 2000)
case fatality ratio The mortality rate of a disease, usually expressed per 100 cases.
(05 Mar 2000)
CD4:CD8 ratio The ratio of CD4 to CD8 cells. A common measure of immune system status that is around two in healthy individuals. The ratio of T-lymphocytes that express the CD4 antigen to those that express the CD8 antigen. This value is commonly assessed in the diagnosis and staging of diseases affecting the immune system including HIV infection.
(12 Dec 1998)
reproductive ratio <epidemiology> 1. Basic reproductive ratio , Ro , a dimensionless parameter which encapsulates the biological details of different transmission mechanisms. For microparasites, Ro , is defined as the average number of secondary cases of infection to which one primary case gives rise throughout its infectious period if introduced into a defined population consisting solely of susceptible individuals. For macroparasites, Ro , is the average number of female offspring (or just offspring in the case of hermaphroditic species) produced throughout the lifetime of a mature female parasite, which themselves achieve reproductive maturity in the absence of density-dependent constraints on the parasite establishment, survival or reproduction.
Also known as the basic reproduction rate, number.
2. Effective reproductive ratio , R , The number of secondary cases (microparasites) or female offspring (macroparasites) produced in a host population not consisting entirely of susceptible individuals (microparasites) or within which density dependent constraints limit parasite population growth (macroparasites). Under conditions of stable endemic infection, R=1.
(05 Dec 1998)
respiratory exchange ratio The ratio of the net output of carbon dioxide to the simultaneous net uptake of oxygen at a given site, both expressed as moles or STPD volumes per unit time; in the steady state, respiratory exchange ratio is equal to the respiratory quotient of metabolic processes.
(05 Mar 2000)
mendelian ratio The ratio of progeny with a particular phenotypes or genotypes expected in accordance with Mendel's law among the offspring of matings specified as to genotype or phenotype.
(05 Mar 2000)
M:E ratio The ratio of myeloid to erythroid precursors in bone marrow; normally it varies from 2:1 to 4:1; an increased ratio is found in infections, chronic myelogenous leukaemia, or erythroid hypoplasia; a decreased ratio may mean a depression of leukopoiesis or normoblastic hyperplasia depending on the overall cellularity of the bone marrow.
(05 Mar 2000)
grid ratio In a radiographic scatter-absorbing grid, the ratio of the height to the width of the gaps between lead strips; a higher grid ratio removes more scattered radiation but requires more careful X-ray tube positioning to avoid grid cutoff of the primary radiation beam.
(05 Mar 2000)
gyromagnetic ratio In nuclear magnetic resonance, the ratio of the magnetic dipole moment of the nucleus to the nuclear spin angular momentum; the gyromagnetic ratio is a unique value for each type of nucleus.
Synonym: magnetogyric ratio.
(05 Mar 2000)
molecular weight ratio The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
P/O ratio A measure of oxidative phosphorylation; the ratio of phosphate radicals esterified (forming adenosine 5'-triphosphate from adenosine 5'-diphosphate) to atoms of oxygen consumed by mitochondria; normally, the ratio is 3 (starting from NADH).
Synonym: P/O quotient.
(05 Mar 2000)
hand ratio The ratio of the length of the hand (measured on the dorsum from the styloid process of the ulna to the tip of the third finger) to the width across the knuckles.
(05 Mar 2000)
segregation ratio In genetics, the proportion of progeny of a particular genotype or phenotype from actual matings of specified genotypes. The test of a Mendelian hypothesis is the comparison of the segregation rate with the Mendelian rate.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á